Objectives: The contact miniTM (CM) is a nonimplantable, digital bone conduction device (BCD) consisting of 2 isolated units: an electronic housing, including the microphone, and a vibrator housing. The study investigated whether the CM can be used as an alternative test device for a BCD trial in single-sided deaf (SSD) adults with the microphone placed at the SSD ear and the vibrator at the normal-hearing (NH) ear (i.e., cross position). Methods: Twenty SSD adults (mean age: 50 [±13.2] years) participated in a 2-week BCD trial with the CM on the headband in cross position. Prior to the trial, the subjects performed adaptive speech-in-noise tests in an unaided condition. After the trial, speech-in-noise tests were performed with the CM in cross position (CMcross) and ipsilateral position, i.e., both units at the SSD ear (CMipsi). Five different speech-in-noise configurations were used (S0N0; S0NNH; S0NSSD; SNNH+SSD; and SSSDNNH). Speech reception thresholds (SRT) were analyzed comparing the unaided, the CMcross condition, and the CMipsi condition. Results: Friedman’s test revealed no significant differences in SRTs between the CMcross, CMipsi, and the unaided condition for the S0N0, S0NNH, S0NSSD, and SNNH+SSD configuration. However, in the SSSDNNH configuration, a significant effect was found (p < 0.001). Wilcoxon pairwise comparisons with Bonferroni correction indicated that SRTs in the CMcross condition were significantly lower (i.e., better speech understanding) than those in the unaided (p < 0.001) and the CMipsi condition (p < 0.05). Conclusion: The CM may be a good alternative for patients with SSD, resulting in significantly better speech recognition when noise is presented to the NH ear and speech to the SSD ear. As the speech recognition results are better in the cross than the ipsilateral position, the CMcross might help to overcome the negative effect of transcranial attenuation during BCD trials.

1.
Arndt
S
,
Aschendorff
A
,
Laszig
R
,
Beck
R
,
Schild
C
,
Kroeger
S
, et al.
Comparison of pseudobinaural hearing to real binaural hearing rehabilitation after cochlear implantation in patients with unilateral deafness and tinnitus
.
Otol Neurotol
.
2011
Jan
;
32
(
1
):
39
47
.
[PubMed]
1531-7129
2.
Arndt
S
,
Laszig
R
,
Aschendorff
A
,
Hassepass
F
,
Beck
R
,
Wesarg
T
.
Cochlear implant treatment of patients with single-sided deafness or asymmetric hearing loss
.
HNO
.
2017
Aug
;
65
(
S2
Suppl 2
):
98
108
.
[PubMed]
0017-6192
3.
Avan
P
,
Giraudet
F
,
Büki
B
.
Importance of binaural hearing
.
Audiol Neurotol
.
2015
;
20
Suppl 1
:
3
6
.
[PubMed]
1420-3030
4.
BHM-Tech Produktionsgesellschaft mbH
. (n.d.). Contact mini: Bone conduction hearing system. Retrieved from http://www.bhm-tech.at/fileadmin/downloads/contact%20mini/16_07_Datenblatt_contactmini_BHM_EN_web.pdf
5.
Briggs
R
,
Van Hasselt
A
,
Luntz
M
,
Goycoolea
M
,
Wigren
S
,
Weber
P
, et al.
Clinical performance of a new magnetic bone conduction hearing implant system: results from a prospective, multicenter, clinical investigation
.
Otol Neurotol
.
2015
Jun
;
36
(
5
):
834
41
.
[PubMed]
1531-7129
6.
den Besten
CA
,
Monksfield
P
,
Bosman
A
,
Skarzynski
PH
,
Green
K
,
Runge
C
, et al.
Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: six-month results from a multicentre study
.
Clin Otolaryngol
.
2018
;
[PubMed]
1749-4478
7.
Gawliczek
T
,
Wimmer
W
,
Munzinger
F
,
Caversaccio
M
,
Kompis
M
.
Speech Understanding and Sound Localization with a New Nonimplantable Wearing Option for Baha
.
BioMed Res Int
.
2018
Sep
;
2018
:
5264124
.
[PubMed]
2314-6133
8.
Kompis
M
,
Pfiffner
F
,
Krebs
M
,
Caversaccio
MD
.
Factors influencing the decision for Baha in unilateral deafness: the Bern benefit in single-sided deafness questionnaire
.
Adv Otorhinolaryngol
.
2011
;
71
:
103
11
.
[PubMed]
0065-3071
9.
Kitterick
PT
,
Smith
SN
,
Lucas
L
.
Hearing Instruments for Unilateral Severe-to-Profound Sensorineural Hearing Loss in Adults: A Systematic Review and Meta-Analysis
.
Ear Hear
.
2016
Sep-Oct
;
37
(
5
):
495
507
.
[PubMed]
0196-0202
10.
Leterme
G
,
Bernardeschi
D
,
Bensemman
A
,
Coudert
C
,
Portal
JJ
,
Ferrary
E
, et al.
Contralateral routing of signal hearing aid versus transcutaneous bone conduction in single-sided deafness
.
Audiol Neurotol
.
2015
;
20
(
4
):
251
60
.
[PubMed]
1420-3030
11.
Lucas
L
,
Katiri
R
,
Kitterick
PT
.
The psychological and social consequences of single-sided deafness in adulthood
.
Int J Audiol
.
2018
Jan
;
57
(
1
):
21
30
.
[PubMed]
1499-2027
12.
Mertens
G
,
De Bodt
M
,
Van de Heyning
P
.
Evaluation of Long-Term Cochlear Implant Use in Subjects With Acquired Unilateral Profound Hearing Loss: Focus on Binaural Auditory Outcomes
.
Ear Hear
.
2017
Jan/Feb
;
38
(
1
):
117
25
.
[PubMed]
0196-0202
13.
Snapp
HA
,
Morgenstein
KE
,
Telischi
FF
,
Angeli
S
.
Transcranial Attenuation in Patients with Single-Sided Deafness
.
Audiol Neurotol
.
2016
;
21
(
4
):
237
43
.
[PubMed]
1420-3030
14.
Stenfelt
S
.
Bilateral fitting of BAHAs and BAHA fitted in unilateral deaf persons: acoustical aspects
.
Int J Audiol
.
2005
Mar
;
44
(
3
):
178
89
.
[PubMed]
1499-2027
15.
Van de Heyning
P
,
Távora-Vieira
D
,
Mertens
G
,
Van Rompaey
V
,
Rajan
GP
,
Müller
J
, et al.
Towards a Unified Testing Framework for Single-Sided Deafness Studies: A Consensus Paper
.
Audiol Neurotol
.
2016
;
21
(
6
):
391
8
.
[PubMed]
1420-3030
16.
van Wieringen
A
,
Wouters
J
.
LIST and LINT: sentences and numbers for quantifying speech understanding in severely impaired listeners for Flanders and the Netherlands
.
Int J Audiol
.
2008
Jun
;
47
(
6
):
348
55
.
[PubMed]
1499-2027
17.
Wendrich
AW
,
Kroese
TE
,
Peters
JP
,
Cattani
G
,
Grolman
W
.
Systematic Review on the Trial Period for Bone Conduction Devices in Single-Sided Deafness: Rates and Reasons for Rejection
.
Otol Neurotol
.
2017
Jun
;
38
(
5
):
632
41
.
[PubMed]
1531-7129
18.
Wie
OB
,
Pripp
AH
,
Tvete
O
.
Unilateral deafness in adults: effects on communication and social interaction
.
Ann Otol Rhinol Laryngol
.
2010
Nov
;
119
(
11
):
772
81
.
[PubMed]
0003-4894
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.